Notice Number: NOT-HL-12-011

Key Dates
Release Date: February 2, 2012

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Background

RFA-HL-09-004 was released January 30, 2009 and the NHLBI Progenitor Cell Biology Consortium was established in the late Fall of 2009. The NHLBI Progenitor Cell Biology Consortium seeks to develop an improved understanding of the biology of stem and progenitor cells, and to harness this knowledge for the diagnosis and treatment of heart, lung, and blood diseases. The Consortium consists of multiple clusters, each forming a virtual Research Hub.  In addition to interactions within Research Hubs, there is extensive collaboration between Hubs.  The Consortium is supported by an Administrative Coordinating Center (ACC) to provide logistical support to the Consortium activities. The ACC is responsible for solicitation of applications for cores and oversees the peer review and award of subcontracts under the guidance of an External Advisory Committee and NHLBI staff.

Purpose
In order to foster synergy and bring new expertise and resources to the Consortium, NHLBI is establishing funding Ancillary/Collaborative Studies. Funds for the Ancillary/Collaborative Studies have been set aside through the Administrative Coordinating Center, which will administer the application, review and funding process.

How to Apply
Additional information and application instructions (http://www.progenitorcells.org/docs/RFA-Anc-Coll.doc ) can be found at the NHLBI Progenitor Cell Biology Consortium website, http://www.progenitorcells.org/. The application deadline is May 15, 2012.

Inquiries

For further information regarding the scientific goals of the Ancillary/Collaborative Studies and the NHLBI Progenitor Cell Biology Consortium, contact:

Denis Buxton, Ph.D.
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute
Rockledge 2, Room 8216
6701 Rockledge Dr, MSC 7940
Bethesda, MD 20892
Telephone: (301) 435-0513
E mail: [email protected]